title: Symptoms of combined prolapse and urinary incontinence in large surgical cohorts.
abstract: OBJECTIVE
  To estimate whether prolapse severity is a major contributor to urinary incontinence severity, as measured by validated incontinence questionnaires.
  
  
  METHODS
  We analyzed data from two large female stress urinary incontinence (SUI) surgical cohorts: the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr) study (N=655) and the subsequent Trial of Mid-Urethral Slings (TOMUS) study (N=597). All participants completed a standardized baseline assessment including validated measures of symptom severity, quality of life, objective measures of urine loss (Urogenital Distress Inventory [UDI], Medical, Epidemiologic, and Social Aspects of Aging questionnaire, Incontinence Impact Questionnaire, and pad test), as well as the Pelvic Organ Prolapse Quantification assessment. Groups were compared using the chi; test (categorical measures) or the one-way analysis of variance (continuous measures). Statistical significance was defined as P<.05.
  
  
  RESULTS
  The SISTEr and TOMUS samples were similar for many variables including age (52 and 53 years, respectively), nulliparity (9% and 12%), prior urinary incontinence (UI) surgery (14% and 13%), and prior hysterectomy (31% and 28%), but other differences necessitated separate analysis of the two cohorts. There was not a statistically significant difference in UDI scores according to prolapse stage in either study population. Patients with prior surgery for pelvic organ prolapse and SUI had more incontinence symptoms and were more bothered by their UI regardless of prolapse stage.
  
  
  CONCLUSIONS
  Prolapse stage is not strongly or consistently associated with incontinence severity in women who select surgical treatment of SUI. Prior pelvic organ prolapse and UI surgery is associated with worse UI severity and bother.
  
  
  BACKGROUND
  ClinicalTrials.gov, www.clinicaltrials.gov, NCT00064662 and NCT00325039.
  
  
  METHODS
  II.
authors.affiliation: From the Departments of Obstetrics and Gynecology and Urology, Loyola University Chicago, Stritch School of Medicine, Chicago, Illinois; the Department of Urology, University of Maryland, Baltimore, Maryland; the New England Research Institutes, Watertown, Massachusetts; the Birmingham VA Medical Center and the Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; the Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas; the Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania; Kaiser Permanente, San Diego, California; the Department of Urology, William Beaumont Hospital, Royal Oak, Michigan; the Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah; and the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
authors.forename: Linda
authors.initials: L
authors.lastname: Brubaker
authors.forename: Leslie
authors.initials: L
authors.lastname: Rickey
authors.forename: Yan
authors.initials: Y
authors.lastname: Xu
authors.forename: Alayne
authors.initials: A
authors.lastname: Markland
authors.forename: Gary
authors.initials: G
authors.lastname: Lemack
authors.forename: Chiara
authors.initials: C
authors.lastname: Ghetti
authors.forename: Margie A
authors.initials: MA
authors.lastname: Kahn
authors.forename: Pradeep
authors.initials: P
authors.lastname: Nagaraju
authors.forename: Peggy
authors.initials: P
authors.lastname: Norton
authors.forename: T Debuene
authors.initials: TD
authors.lastname: Chang
authors.forename: Anne
authors.initials: A
authors.lastname: Stoddard
mesh_terms: D005260:Female; D006801:Humans; D008875:Middle Aged; D053825:Suburethral Slings; D011795:Surveys and Questionnaires; D014550:Urinary Incontinence, Stress / Q000150:complications / Q000175:diagnosis*; D014596:Uterine Prolapse / Q000150:complications / Q000175:diagnosis* / Q000601:surgery